AzTrials
AzTrials

Preoperative Anxiety ScoreNCT07911436

Virtual Reality to Reduce Anxiety During Thoracic Epidural Placement.

A study testing VR- headset in people with Preoperative Anxiety Score, run by Universitaire Ziekenhuizen KU Leuven.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The purpose of this study is to investigate whether using a Virtual Reality (VR) headset can help young people relax during the placement of an epidural catheter for pain control after pectus surgery. An epidural catheter is a thin tube that is inserted by the anesthesiologist between two vertebrae in the back. Read more about this study

Who is it for?
Ages 13 to 19 years
Conditions the study is for
Preoperative Anxiety Score
What is being tested?
VR- headset
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
78 participants
Where
No sites listed yet
Study dates
1 Nov 2026to 31 Aug 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 13 to 19 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • Voluntary written informed assent of the minor participant + consent of their legally authorized representative or voluntary written informed consent of the adult participant has been obtained prior to any screening procedures
  • Between 13 \& 19 years of age at the time of signing the Informed Consent Form (ICF)
  • Scheduled for elective Pectus Excavatum or Carinatum repair (Nuss/Ravitch) with planned Thoracic Epidural Analgesia (TEA).
  • ASA I-III
  • Proficiency in Dutch to allow self-assessment via VAS-Anxiety

Who cannot join

  • Patient has history of Epilepsy or Seizure Disorder
  • Regular use of anxiolytics, sedatives, or psychoactive medication at home.
  • Deafness or blindness preventing VR engagement or VAS self-assessment.
  • Known contraindication to TEA (e.g., coagulopathy) or refusal of TEA.
  • Urgent or emergency surgery.

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Geertrui Dewinter, Phd, MD contact

+32 16 34 4270

geertrui.dewinter@uzleuven.be

About this study

Official title: Efficacy of Virtual Reality Distraction on Procedural Anxiety in Adolescents Undergoing Epidural Placement for Pectus Surgery: An Open-Label Prospective Randomized Controlled Trial.

The purpose of this study is to investigate whether using a Virtual Reality (VR) headset can help young people relax during the placement of an epidural catheter for pain control after pectus surgery.

An epidural catheter is a thin tube that is inserted by the anesthesiologist between two vertebrae in the back. Many teenagers experience anxiety or stress during the placement of this catheter.

Read more

To help reduce anxiety, medication called Midazolam can be given through an IV line. However, this does not always provide enough relief. Scientific studies have shown that virtual reality (VR) can help reduce anxiety, stress, and pain during medical procedures. By focusing on a virtual environment, patients are less aware of the procedure itself. In particular, VR has been shown to be a safe and effective way of improving comfort for children and adolescents during medical examinations and treatments.

A total of 78 adolescents aged 13 to 19 years will participate in this study. Participants will be randomly assigned to one of two groups, each consisting of 39 participants:

Children in the interventional group will wear a VR headset during the placement of the epidural catheter. If the child still experiences significant anxiety or stress during the procedure, Midazolam will be administered through the IV line.

Children assigned to the control group will receive the usual care. This means that Midazolam will be given through the IV line if your child experiences significant anxiety or stress. Children in this group will not receive a VR headset.

Being tested
VR- headset
Keywords
Epidural katheter, Preoperative anxiety, virtual reality

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • VR- headsetDevice

    Children will wear a VR headset during the placement of the epidural catheter.

Study groups in NCT07911436
Study groupRoleWhat they receive
Control groupNo interventionChildren will receive the usual care.
Interventional groupExperimentalChildren will wear a Virtual Reality headset during the placement of the epidural catheter.
Receives: Device: VR- headset

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Postprocedural anxiety score

    Subjective Anxiety/stress measured by the VAS from 0 (no anxiety/distress) and 100mm (extreme anxiety/distress)

    Measured: postprocedural until 10 min after procedure

Secondary outcomes (6)
  1. anxiety assessments by the physician performing the epidural, the assisting nurse and accompanying parent, reflecting their perception of the patient's anxiety (NRS)

    measured by the VAS from 0 (no anxiety/distress) and 100mm (extreme anxiety/distress)

    Measured: 10 min preprocedural

  2. anxiety questionnaire from the patient

    anxiety questionnaire from the patient

    Measured: 10 min preprocedural

  3. - Rescue sedation medication during placement of the epidural catheter

    dose of Midazolam in mg

    Measured: during the procedure

  4. - Efficacy of epidural placement:

    Time and number of attempts

    Measured: during the procedure

  5. patient satisfaction score

    NRS: from 0-10, 0=not satisfied and 10=very satisfied

    Measured: postprocedural until 10 min after procedure

  6. - Pain score of placement of the epidural catheter

    NRS from 0-10, 0=no pain and 10=worst pain)

    Measured: postprocedural until 10 min after procedure

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Nov 2026
  2. Study start1 Nov 2026 (estimated)
  3. Primary completion31 Aug 2028 (estimated)
  4. Study completion31 Aug 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
78 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07911436
Sponsor's protocol ID
S71981
Status last verified
Oct 2026
First submitted
16 Oct 2026
Last updated
2 Nov 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing VR- headset in people with Preoperative Anxiety Score, run by Universitaire Ziekenhuizen KU Leuven.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 2 Nov 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Geertrui Dewinter, Phd, MD (+32 16 34 4270, geertrui.dewinter@uzleuven.be), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Postprocedural anxiety score (time frame: postprocedural until 10 min after procedure). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in